Authors


Mary Alice O’Dowd, MD

Latest:

Introduction: A Biopsychosocial Model of Care

The past decade has been an exciting one for the field of psychosomatic medicine. It has been recognized as a specialty and now has a certification examination. In this Special Report, we discuss some of the approaches that are being taken to special populations within the psychosomatic medicine community.


Mary Amanda Dew, PhD

Latest:

Key Stressors in Transplant Psychiatry

Here: A summary of indicators for stress and anxiety in patients undergoing transplantation, and why it is important for psychiatrists to be aware of these factors.


Mary Ann Cohen, MD

Latest:

What Psychiatrists Need to Know About the Determination of Dispositional Capacity

Some of the most challenging decisional capacity consultations are requests to determine if a patient has the capacity to participate in discharge planning.


Mary Beth Beaudry, RN, MSN, MPH

Latest:

Touched With Fire: Film and Social Media Address Stigma

Film can be a powerful vehicle for conversation and social change in the fight against psychiatric stigma.


Mary Beth Cogan

Latest:

Diagnosis and Treatment of Bipolar Disorder in Children and Adolescents

Since 1980, criteria for diagnosing bipolar disorder in adults have also been used to diagnose mania in children, with some modifications to adjust for age.


Mary C. Zeng, MD

Latest:

Bereavement, Grief, and Depression: Clinical Update and Implications

An in-depth CME on DSM-5 criteria for persistent complex bereavement disorder and the clinical management of pathological reactions to the death of a loved one.


Mary Clair, PhD

Latest:

Special Risk Management Issues in Child and Adolescent Psychiatry

Numerous studies have documented the increasing prevalence of mental health and substance abuse issues in youths nationwide. As many as 1 in 5 children and adolescents in the United States have a behavioral or emotional disorder.


Mary Davis, PhD

Latest:

Behavioral Comorbidities in Rheumatoid Arthritis

While tremendous therapeutic advancements have been made, patients with rheumatoid arthritis (RA) have a myriad of comorbidities, including fatigue, depression, and sleep disturbances. Data on the comorbidity of psychiatric disorders with arthritis are also striking: according to the NIMH Catchment Area program, the lifetime prevalence of psychiatric disorders among patients with RA is 63%.


Mary Dobbins, MD

Latest:

Nonverbal Learning Disabilities and Sensory Processing Disorders

In our presentation at the 2006 annual meeting of the American Academy of Child and Adolescent Psychiatry, we suggested that child psychiatrists who come across a child with the profile of the following hypothetical case should consider whether the child may have deficits that are not currently covered by DSM-IV nosology: either a nonverbal learning disability (NVLD) or a sensory processing disorder (SPD).


Mary E. Dozier

Latest:

Hoarding in Late Life: Implications for Clinicians

DSM-5 criteria for hoarding disorder necessitate that the hoarding behaviors cause clinically significant impairment in the patient’s ability to function.


Mary E. Woesner, MD

Latest:

The Treatment Around the Corner

A psychiatrist attempts to stay positive while facing her parents' and loved ones' premature deaths-ever reminding us that hope springs eternal.


Mary Ellen Trunko, MD

Latest:

Pharmacological Management of Treatment-Resistant Anorexia Nervosa

Only 13% to 50% of AN patients are considered recovered 1 to 2 years posttreatment, and 20% to 30% go on to develop a chronic and unremitting course of AN. How can we improve these outcomes?


Mary G. Burke, MD

Latest:

The Impact of Screen Media on Children

In essence, screen media constitute neurologically potent, arousing input to the developing brain. Unlike conventional toxins, their effects are mediated by sense organs. However, they have demonstrable effects on brain activity, and on behavior and function.


Mary Margaret Gleason, MD

Latest:

Collaborative and Integrated Care in Pediatrics: Part of the Solution to the Child Mental Health Crisis

In this CME, learn more about implementing formal or informal collaboration with the primary care clinicians with whom you share care of your child patients.


Mary Mcaweeney, PhD

Latest:

The Substance Abuse Handbook

The Substance Abuse Handbook offers a comprehensive, clinically oriented approach to the treatment of addictive disorders. It contains a wealth of useful information, ranging from causes of addiction to different modes of treatment.


Mary Roessel, MD

Latest:

Next Steps: Solutions and Recommendations For Healing

Climate change is a devastating existential threat that can exaggerate preexisting inequities and health/mental health problems. As mental health professionals committed to understanding deep emotional wounds and addressing complexities of relationships, psychiatrists have the tools to assist in bridging the current gaps.


Mary S. Esther, MD

Latest:

Sleep Disturbances with Substances of Abuse and Dependence

Sleep disorders and substance abuse disorders are widespread acrossthe United States, researchers have found. According to the NationalCommission on Sleep Disorders Research, more than 80 million Americanscomplain of sleep difficulties, while Schuckit and Irwin reportedthe lifetime prevalence of alcohol abuse or dependence to be 13percent and nonalcohol drug abuse, 5.9 percent.


Mary T. Thigpen, PhD

Latest:

Developing Clinical Evidence for Locomotor Training

Locomotor training is an emerging rehabilitation intervention to help patients who have spinal cord injuries or who are recovering from stroke walk again. The basis for the intervention lies in understanding the neurobiology of walking and the nervous system's capacity for activity-dependent plasticity.


Mary V. Seeman, MDCM, DSc

Latest:

When Eating Disorders and Psychosis Co-Exist: 6 Take Home Points

The body image disturbance at the heart of anorexia nervosa is a false perception akin to the perceptual disorders found in schizophrenia.


Marya Morozova

Latest:

Understanding the Neurobiological Basis of Drug Abuse: Comorbidity in Schizophrenia

It is clear that the prognosis for schizophrenia is much better when patients achieve drug abstinence, including in the domains of depression, quality of life, and community integration.


Maryam Sharif-Razi

Latest:

Schizophrenia, Neurocognitive Dysfunction, and Substance-Related Disorders: A Review

The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.


Maryland Pao, MD

Latest:

Psychiatrists as Partners in Suicide Prevention for Pediatric Medical Settings

"The death rate among youth aged 10 to 24 years increased 52.2% from 6.9 per 100,000 in 2001 to 10.5 per 100,000 in 2020."


Matcheri S. Keshavan, MD

Latest:

Developing a Collaborative Approach to Post-Acute Sequelae of SARS-CoV-2 Infection

1 in 3 COVID-19 survivors experience persistent consequences. What can psychiatry do to help?


Matilde Inglese, MD, PhD

Latest:

The Role of MRI in the Diagnosis of Multiple Sclerosis

Multiple sclerosis (MS) is the most commoninflammatory demyelinating disease of theCNS and the most frequent cause of nontraumaticneurological disability in young andmiddle-aged adults.1 Women are twice as likelyto be affected as men, and onset typicallyoccurs between the ages of 20 and 40 years.


Matt G. Kushner, PhD

Latest:

Substance Abuse Screening in Patients With Anxiety Disorders

How can clinicians reliably identify comorbid drug and alcohol use disorders in patients with anxiety disorders?


Matt Goldenberg, DO

Latest:

Patient Education: 11 Common Questions on Heroin Abuse

A guide for helping patients understand heroin, its history, and how it impacts our communities.


Matthew A. Menza, MD

Latest:

Psychiatric Symptoms Associated With Parkinson Disease

Parkinson disease (PD) is the second most common neurodegenerative illness in the United States, affecting more than 1 million persons. Disease onset is usually after age 50. In persons older than 70 years, the prevalence is 1.5% to 2.5%.1 While the primary pathology involves degeneration of dopaminergic neurons in the substantia nigra, circuits important in emotion and cognition-such as the serotonergic, adrenergic, cholinergic, and frontal dopaminergic pathways-are also variably disrupted.


Matthew D. Erlich, MD

Latest:

Addressing the Aftermath of Suicide: Why We Need Postvention

Here: a brief review of the literature on postvention efforts; the effects on the victim’s caregivers; and a guide to resources to help manage survivors’ and caregivers’ emotions and dread.


Matthew J. Friedman, MD, PhD

Latest:

Addressing Postdeployment Needs

Although we would all like to believe otherwise, war is not over when a service member returns home. For many, returning home may be where the harder battles begin. Intensive training prepares troops for warfare, but what training do they have to readjust when they return home?


Matthew L. Goldman, MD

Latest:

Improving Mental Health Care in America: An Opportunity for Comprehensive Reform

The authors outline the ingredients for the transformation of mental health care in America.

© 2024 MJH Life Sciences

All rights reserved.